Home Tags Drug Companies

Tag: Drug Companies

Rep. Alexandria Ocasio-Cortez on May 16 confronted the CEO of a drug company of the high cost of an HIV prevention drug.

GOP voters agree with Alexandria Ocasio-Cortez when it comes to one of the thorniest questions in health care

About 65% of Republicans agree the government should play at least some role in influencing prices of drugs like Truvada — an HIV-preventing drug.
A drug company tried energy trading, and things didn't go as planned.

A tiny diabetes drug maker in Norway decided to get into energy trading — and failed spectacularly

Vistin Pharma, known for its type-2 diabetes drug Metformin, said in March that it would try its hand at the energy market. Things didn't go to plan.

RANKED: These are the most and least reputable drug companies in the world

The Reputation Institute took a look at what the general public thought of 17 major pharmaceutical companies. Here's who came out on top.

Valeant’s collapse — from Clinton’s tweet to Ackman’s exit

Valeant Pharmaceuticals' stock price has been falling over the past year and a half. Here are the events that punctuated that demise.

A breakthrough approach to treating Alzheimer’s is facing major setbacks

Merck has become the latest drugmaker to face a setback to finding drugs to treat Alzheimer's disease.

The FTC is suing 2 drug companies for obstructing generic competition

Allergan and Endo Pharmaceuticals are being sued for obstructing generic drug competition.

Morgan Stanley weighs in on the 9 big questions that will dominate Wall Street in 2017

BI breaks down Morgan Stanley's 2017 edition of Big Debates in which they weigh in on the main debates that will shape the markets in the new year.

Drug spending around the world will hit $1.5 trillion by 2021

The amount of money the world will be spending on drugs will hit $1.5 trillion by 2021, up from roughly $1.2 trillion in 2016, according to a new report.

Drug stocks rip higher after Trump’s upset victory signals easing pressure on prices

The win on Prop 61, coupled with a Trump presidency has sent the entire pharmaceutical industry soaring. The NASDAQ biotechnology index was up 8%.

We have the technology to fast-track drug development, but we’re not using it yet

According to a new report, there are some areas where big data can be used to benefit patients, but aren't being used to their fullest potential just yet.